Clinical Trials Sponsored by Oscotec Inc.

Total 35429 results

Oscotec Inc.

Completed

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

United States, Greece, Korea, Republic of, Poland, Spain
Oscotec Inc.

Unknown

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Rheumatoid Arthritis

United States, Czechia, Poland, Russian Federation, Ukraine
Oscotec Inc.

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Korea, Republic of
Oscotec Inc.

Completed

A Study of the Absorption, Metabolism, and Excretion of [14C]-SKI-O-703 Following a Single Oral Dose in Healthy Male Subjects

Healthy Volunteers

United States
Oscotec Inc.
PPD

Completed

Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States
Oscotec Inc.
PPD

Completed

Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers

Rheumatoid Arthritis

United States
Oscotec Inc.
PPD

Completed

Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers

Arthritis, Rheumatoid

United States
Alzheimer's Disease Expert Lab (ADEL), Inc.
Oscotec Inc.

Recruiting

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Alzheimer Disease

United States
Consorzio Oncotech

Active, not recruiting

Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients (GIM 23- POSTER)

Early Breast Cancer

Italy
Consorzio Oncotech

Unknown

Overcoming Endocrine Resistance in Metastatic Breast Cancer (OVER)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Recruiting

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Italy
Consorzio Oncotech

Completed

Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study (ARIES)

Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer

Italy
Consorzio Oncotech

Active, not recruiting

Atezolizumab Plus CArboplatin Plus Nab-paclitaxel

Metastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene Mutation

Italy
Consorzio Oncotech

Active, not recruiting

Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Unknown

Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin (LUNG-NEPA)

Chemotherapy-induced Nausea and Vomiting

Italy
Consorzio Oncotech

Completed

NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer (GIM15-NEPA)

Chemotherapy-induced Nausea and Vomiting
Consorzio Oncotech

Unknown

Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments (BIO-META)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Completed

FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC (GIM9)

Breast Cancer

Italy
Fondazione Oncotech

Not yet recruiting

NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer (Neo-AGILE)

Breast Cancer

Italy
Consorzio Oncotech

Recruiting

Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer (PE-PE)

Oligometastatic Renal Cell Carcinoma

Italy
Consorzio Oncotech

Completed

Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial) (GIM21)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Unknown

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Prostate Cancer | Castration-resistant Prostate Cancer

Italy
Consorzio Oncotech
Pfizer

Recruiting

Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients (AxIn)

Metastatic Renal Cell Carcinoma

Italy
OncoSec Medical Incorporated

Terminated

Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma (CTCL)

Mycosis Fungoides (MF) | Cutaneous T Cell Lymphomas (CTCL)

United States
OncoSec Medical Incorporated

Completed

Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC (TNBC)

ER-Negative PR-Negative HER2-Negative Breast Cancer

United States
OncoSec Medical Incorporated

Completed

Trial of pIL-12 Electroporation Malignant Melanoma (IL-12MEL)

Melanoma

United States
OncoSec Medical Incorporated

Terminated

Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)

Head and Neck Squamous Cell Carcinoma

United States
Sciotec Diagnostic Technologies GmbH

Completed

Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity

Food Intolerance | Histamine Intolerance

Austria
Acotec Scientific Co., Ltd

Recruiting

ACOART AVF RENEW: A Post Market Clinical Study

Stenosis of Native Hemodialysis Arteriovenous Fistulas

China
Acotec Scientific Co., Ltd

Recruiting

Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis

Peripheral Artery Disease

China
Acotec Scientific Co., Ltd

Active, not recruiting

AcoArt VI / Vertebral Artery Ostium Stenosis in China

Ischemic Stroke | Transient Ischemic Attack

China
Acotec Scientific Co., Ltd

Completed

AcoArt IV / SFA in China:Drug-eluting Balloon for SFA Angioplasty Evaluation in China

Peripheral Artery Disease

China
Sciotec Diagnostic Technologies GmbH

Not yet recruiting

Observational Study on the Safety and Efficacy of the Medical Product Fructosin.

Fructose Intolerance

Austria
Providence Health & Services
OncoSec Medical Incorporated

Completed

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) (CORVax12)

SARS-CoV-2

United States
Acotec Scientific Co., Ltd

Recruiting

Acotec DCB Post Market Clinical Follow-up (FLOWER)

Peripheral Artery Disease

Germany
Acotec Scientific Co., Ltd

Completed

AcoArt III / Arterio-venous Fistula in China

Arteriovenous Fistula Stenosis

China
Acotec Scientific Co., Ltd

Completed

AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China

Peripheral Artery Disease

China
Acotec Scientific Co., Ltd

Completed

AcoArt Ⅰ / SFA China

Peripheral Artery Disease

China
Acotec Scientific Co., Ltd

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.

Peripheral Arterial Disease (PAD) | Peripheral Vascular Disease (PVD)

China
Acotec Scientific Co., Ltd

Recruiting

ACOART BTK RENEW：A Post Market Clinical Study

Peripheral Artery Disease

China
Acotec Scientific Co., Ltd

Completed

Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure

Peripheral Arterial Disease

China
Consorzio Oncotech
Roche Pharma AG

Recruiting

Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy

Breast Cancer

Italy
Oncotech

Unknown

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Breast Cancer

United States
Asociación Canaria de Terapias Creativas (ASCATEC)

Active, not recruiting

Neuropsychological and Electrophysiological Effects of Dance Therapy With People With Severe Mental Disorders

Severe Mental Disorder

Spain
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients (GIM11-BERGI)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer (FEVEX)

Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant Neoplasm

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients (FUMANCE)

Metastatic Breast Cancer

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Recruiting

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma (TIDE-A)

Renal Carcinoma Metastatic

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies

Metastatic Breast Cancer

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Observation of Medical Treatments in MBC HER2-negative Patients (AMBRA)

Metastatic Breast Cancer

Italy

3

Subscribe